A detailed history of Arvest Bank Trust Division transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arvest Bank Trust Division holds 33,320 shares of BMY stock, worth $1.97 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
33,320
Previous 14,440 130.75%
Holding current value
$1.97 Million
Previous $854,000 201770.73%
% of portfolio
0.1%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$39.66 - $51.75 $748,780 - $977,040
18,880 Added 130.75%
33,320 $1.72 Billion
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $246,679 - $288,953
4,169 Added 40.59%
14,440 $854,000
Q2 2021

Aug 19, 2021

BUY
$61.91 - $67.42 $635,877 - $692,470
10,271 New
10,271 $686,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Arvest Bank Trust Division Portfolio

Follow Arvest Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Arvest Bank Trust Division with notifications on news.